Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 407-418

  Faure, A ^a   Verret, L ^b   Bozon, B ^a   El Tannir El Tayara, N ^c,d   Ly, M ^a   Kober, F ^e   Dhenain, M ^f,g,h   Rampon, C ^b   Delatour, B ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Université Paul Sabatier   (France)

^c Centre Universitaire   (France)

^d INSTITUT CURIE   (France)

^e University of Aix Marseille   (France)

^f SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^g SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^h CEA SACLAY   (France)

Author keywords

Alzheimer's disease; Amyloid peptide; Brain blood perfusion; Hippocampus; Learning and memory; Neurogenesis

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; LOCOMOTION; MEMORY DISORDER; MOTOR PERFORMANCE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPATIAL MEMORY;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANXIETY; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MOTOR ACTIVITY; MOVEMENT DISORDERS; MUTATION; NEUROGENESIS; NEUROLOGIC EXAMINATION; PRESENILIN-1;

EID: 79952899908     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.03.009     Document Type: Article

References (46)

1. Asllani I., Habeck C., Scarmeas N., Borogovac A., Brown T.R., Stern Y. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J. Cereb. Blood Flow Metab. 2008, 28(4):725-736.
2. Bayer T.A., Breyhan H., Duan K., Rettig J., Wirths O. Intraneuronal beta-amyloid is a major risk factor-novel evidence from the APP/PS1KI mouse model. Neurodegener. Dis. 2008, 5(3-4):140-142.
3. Bayer T.A., Wirths O. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav. 2008, 7(Suppl. 1):6-11.
4. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T.A., Langui D., Duyckaerts C., Tremp G., Pradier L. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 2003, 184(1):247-263.
5. Burguiere E., Arleo A., Hojjati M.R., Elgersma Y., Zeeuw C.I., Berthoz A., Rondi-Reig L. Spatial navigation impairment in mice lacking cerebellar LTD: a motor adaptation deficit?. Nat. Neurosci. 2005, 8(10):1292-1294.
6. Calhoun M.E., Wiederhold K.H., Abramowski D., Phinney A.L., Probst A., Sturchler-Pierrat C., Staufenbiel M., Sommer B., Jucker M. Neuron loss in APP transgenic mice. Nature 1998, 395(6704):755-756.
7. Casas C., Sergeant N., Itier J.M., Blanchard V., Wirths O., van der Kolk N., Vingtdeux V., van de Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T.A., Benoit P., Pradier L. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 2004, 165(4):1289-1300.
8. Christensen D.Z., Bayer T.A., Wirths O. Intracellular Abeta triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiol. Aging 2008, 10.1016/j.neurobiolaging.2008.07.022.
9. Christensen D.Z., Kraus S.L., Flohr A., Cotel M.C., Wirths O., Bayer T.A. Transient intraneuronal Abeta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathol. 2008, 116(6):647-655.
10. Cotel M.C., Bayer T.A., Wirths O. Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice. Brain Res. 2008, 1222:207-213.
11. Cummings J.L. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997, 48(5 Suppl. 6):S10-S16.
12. Damjanac M., Rioux Bilan A., Paccalin M., Pontcharraud R., Fauconneau B., Hugon J., Page G. Dissociation of Akt/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007, 29(2):354-367.
13. Gallagher M., Burwell R., Burchinal M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav. Neurosci. 1993, 107(4):618-626.
14. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256(5054):184-185.
15. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 1997, 17(18):7053-7059.
16. Janus C., D'Amelio S., Amitay O., Chishti M.A., Strome R., Fraser P., Carlson G.A., Roder J.C., St George-Hyslop P., Westaway D. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol. Aging 2000, 21(4):541-549.
17. Janus C., Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 2001, 73(5):873-886.
18. Johnson N.A., Jahng G.H., Weiner M.W., Miller B.L., Chui H.C., Jagust W.J., Gorno-Tempini M.L., Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005, 234(3):851-859.
19. Kober F., Duhamel G., Cozzone P.J. Experimental comparison of four FAIR arterial spin labeling techniques for quantification of mouse cerebral blood flow at 4.7T. NMR Biomed. 2008, 21(8):781-792.
20. Laferla F.M., Green K.N., Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 2007, 8(7):499-509.
21. Le Cudennec C., Faure A., Ly M., Delatour B. One-year longitudinal evaluation of sensori-motor functions in APP751SL transgenic mice. Genes Brain Behav. 2008, 7(Suppl. 1):83-92.
22. Li B., Yamamori H., Tatebayashi Y., Shafit-Zagardo B., Tanimukai H., Chen S., Iqbal K., Grundke-Iqbal I. Failure of neuronal maturation in Alzheimer disease dentate gyrus. J. Neuropathol. Exp. Neurol. 2008, 67(1):78-84.
23. Luo F., Seifert T.R., Edalji R., Loebbert R.W., Hradil V.P., Harlan J., Schmidt M., Nimmrich V., Cox B.F., Fox G.B. Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in mice. Neuroscience 2008, 155(1):263-269.
24. Niwa K., Kazama K., Younkin S.G., Carlson G.A., Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol. Dis. 2002, 9(1):61-68.
25. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006, 26(40):10129-10140.
26. Page G., Rioux Bilan A., Ingrand S., Lafay-Chebassier C., Pain S., Perault Pochat M.C., Bouras C., Bayer T., Hugon J. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 2006, 139(4):1343-1354.
27. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55(5):697-711.
28. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego. second ed.
29. Pietropaolo S., Feldon J., Yee B.K. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease. Behav. Neurosci. 2008, 122(4):733-747.
30. Rogers D.C., Fisher E.M., Brown S.D., Peters J., Hunter A.J., Martin J.E. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 1997, 8(10):711-713.
31. Scher A.I., Xu Y., Korf E.S., White L.R., Scheltens P., Toga A.W., Thompson P.M., Hartley S.W., Witter M.P., Valentino D.J., Launer L.J. Hippocampal shape analysis in Alzheimer's disease: a population-based study. Neuroimage 2007, 36(1):8-18.
32. Schmitz C., Rutten B.P., Pielen A., Schafer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H.W., Pradier L., Bayer T.A. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 2004, 164(4):1495-1502.
33. Sun Y., Schmidt N.O., Schmidt K., Doshi S., Rubin J.B., Mulkern R.V., Carroll R., Ziu M., Erkmen K., Poussaint T.Y., Black P., Albert M., Burstein D., Kieran M.W. Perfusion MRI of U87 brain tumors in a mouse model. Magn. Reson. Med. 2004, 51(5):893-899.
34. Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Hsiao Ashe K., Hasegawa M., Mann D.M., Hyman B.T., Iwatsubo T. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am. J. Pathol. 2000, 157(1):331-339.
35. Urbanc B., Cruz L., Le R., Sanders J., Ashe K.H., Duff K., Stanley H.E., Irizarry M.C., Hyman B.T. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(22):13990-13995.
36. Verret L., Jankowsky J.L., Xu G.M., Borchelt D.R., Rampon C. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J. Neurosci. 2007, 27(25):6771-6780.
37. Vicens P., Bernal M.C., Carrasco M.C., Redolat R. Previous training in the water maze: differential effects in NMRI and C57BL mice. Physiol. Behav. 1999, 67(2):197-203.
38. Vicens P., Redolat R., Carrasco M.C. Effects of early spatial training on water maze performance: a longitudinal study in mice. Exp. Gerontol. 2002, 37(4):575-581.
39. Walsh D.M., Selkoe D.J. Abeta Oligomers-a decade of discovery. J. Neurochem. 2007, 101(5):1172-1184.
40. West M.J., Kawas C.H., Martin L.J., Troncoso J.C. The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann. N. Y. Acad. Sci. 2000, 908:255-259.
41. Williams D.S., Detre J.A., Leigh J.S., Koretsky A.P. Magnetic-resonance-imaging of perfusion using spin inversion of arterial water. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(1):212-216.
42. Wirths O., Bayer T. Early intraneuronal β-amyloid pathology: do transgenic mice represent valid model systems?. Open Aging J. 2008, 2:7-12.
43. Wirths O., Bayer T.A. Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models. Genes Brain Behav. 2008, 7(Suppl. 1):1-5.
44. Wirths O., Breyhan H., Schafer S., Roth C., Bayer T.A. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease. Neurobiol. Aging 2007, 29(6):891-901.
45. Wirths O., Weis J., Kayed R., Saido T.C., Bayer T.A. Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol. Aging 2006, 28(11):1689-1699.
46. Wolfer D.P., Madani R., Valenti P., Lipp H.P. Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol. Behav. 2001, 73(5):745-753.